- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 24
  num_fold: 3874
  S: 3069
  I: 721
  R: 84
  median_fold: 1.9
  percent: 4.4
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 21
  num_fold: 1048
  S: 790
  I: 222
  R: 36
  median_fold: 2.5
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 173
  num_fold: 19044
  S: 13593
  I: 4370
  R: 1081
  median_fold: 2.8
  percent: 22.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 43
  num_fold: 2537
  S: 1662
  I: 770
  R: 105
  median_fold: 3.1
  percent: 2.9
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 60
  num_fold: 4780
  S: 2927
  I: 1601
  R: 252
  median_fold: 4.0
  percent: 5.4
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 9
  num_fold: 305
  S: 219
  I: 74
  R: 12
  median_fold: 3.6
  percent: 0.34
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.18
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.016
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 64
  num_fold: 8261
  S: 5798
  I: 2138
  R: 325
  median_fold: 3.6
  percent: 9.3
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 354
  S: 250
  I: 84
  R: 20
  median_fold: 3.1
  percent: 0.4
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 18
  num_fold: 3593
  S: 2794
  I: 777
  R: 22
  median_fold: 4.3
  percent: 4.1
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 8
  num_fold: 838
  S: 408
  I: 177
  R: 253
  median_fold: 6.3
  percent: 0.95
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.049
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 37
  num_fold: 2362
  S: 1485
  I: 630
  R: 247
  median_fold: 3.8
  percent: 2.7
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 12
  num_fold: 484
  S: 424
  I: 37
  R: 23
  median_fold: 1.7
  percent: 0.55
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 447
  S: 201
  I: 246
  R: 0
  median_fold: 5.8
  percent: 0.5
  priority: 3
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 9
  num_fold: 2418
  S: 1284
  I: 799
  R: 335
  median_fold: 4.3
  percent: 2.7
  priority: 5
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 499
  S: 100
  I: 398
  R: 1
  median_fold: 20.0
  percent: 0.56
  priority: 5
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.54
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.19
  priority: 6
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.15
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 70
  S: 2
  I: 68
  R: 0
  median_fold: 8.0
  percent: 0.079
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 17
  num_fold: 1898
  S: 1328
  I: 550
  R: 20
  median_fold: 2.9
  percent: 2.1
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.28
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 8
  num_fold: 1152
  S: 425
  I: 727
  R: 0
  median_fold: 5.2
  percent: 1.3
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 938
  S: 559
  I: 379
  R: 0
  median_fold: 3.6
  percent: 1.1
  priority: 7
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 253
  S: 110
  I: 72
  R: 71
  median_fold: 7.3
  percent: 0.29
  priority: 8
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 611
  S: 172
  I: 399
  R: 40
  median_fold: 8.1
  percent: 0.69
  priority: 10
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 568
  S: 396
  I: 130
  R: 42
  median_fold: 4.0
  percent: 0.64
  priority: 11
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 20
  num_fold: 1260
  S: 849
  I: 343
  R: 68
  median_fold: 2.9
  percent: 1.4
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 7
  num_fold: 180
  S: 130
  I: 44
  R: 6
  median_fold: 2.6
  percent: 0.2
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 426
  S: 231
  I: 179
  R: 16
  median_fold: 4.9
  percent: 0.48
  priority: 12
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.28
  priority: 21
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.24
  priority: 22
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 317
  S: 76
  I: 238
  R: 3
  median_fold: 7.7
  percent: 0.36
  priority: 29
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.27
  priority: 31
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 4840
  S: 4808
  I: 32
  R: 0
  median_fold: 2.7
  percent: 5.5
  priority: 32
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 76
  S: 0
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.086
  priority: 35
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 142
  S: 42
  I: 82
  R: 18
  median_fold: 6.6
  percent: 0.16
  priority: 37
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.3
  priority: 38
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 8
  num_fold: 569
  S: 372
  I: 191
  R: 6
  median_fold: 1.6
  percent: 0.64
  priority: 39
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 92
  S: 68
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.1
  priority: 39
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 62
  S: 6
  I: 56
  R: 0
  median_fold: 7.5
  percent: 0.07
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0068
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 498
  S: 414
  I: 84
  R: 0
  median_fold: 2.6
  percent: 0.56
  priority: 41
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.24
  priority: 42
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.1
  priority: 43
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 11
  num_fold: 805
  S: 393
  I: 233
  R: 179
  median_fold: 5.2
  percent: 0.91
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 3
  num_fold: 42
  S: 29
  I: 10
  R: 3
  median_fold: 3.0
  percent: 0.047
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 555
  S: 346
  I: 209
  R: 0
  median_fold: 3.5
  percent: 0.63
  priority: 46
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.2
  priority: 47
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.77
  priority: 47
- vaccine: AZD1222 + mRNA
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 52
  R: 8
  median_fold: 9.4
  percent: 0.068
  priority: 52
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 814
  S: 639
  I: 114
  R: 61
  median_fold: 2.2
  percent: 0.92
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 358
  S: 271
  I: 79
  R: 8
  median_fold: 2.8
  percent: 0.4
  priority: 1000
